Project Grant 2528478
Award Date 7/1/26
Completion Date 3/31/27
Dollars Obligated $305K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Diego, CA 92121, USA
Similar Awards
- Federal Grant Award Summary Particle4X, Inc. received a $304,972 Phase I Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) effective October 1, 2025, through September 30, 2026. The company is developing a compact, real-time inline monitoring sensor system for injectable drug manufacturing that integrates digital inline holography (DIH) and deep learning algorithms to simultaneously...
- Federal Grant Award Summary Nanoplasmonics LLC received a $304,780 Phase I Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on June 1, 2025, to develop breakthrough sensor technology for mycotoxin detection in the food supply chain. The project, based in Colorado Springs, Colorado, will be completed by May 31, 2026. The primary deliverable is an innovative detection system that...
- Federal Project Grant Award Summary Synlibris, Inc. received a $304,957 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation's Directorate for Technology, Innovation, and Partnerships (CFDA 47.084) effective July 1, 2026, through June 30, 2027. The project develops a continuous evolution platform technology designed to accelerate the discovery of genetic solutions for high-yield protein biomanufacturing. The core innovation utilizes an orthogonal DNA...
- Federal Project Grant Summary Phase, Inc. received a $304,761 National Science Foundation (NSF) Small Business Technology Transfer (STTR) Phase I award under the Technology, Innovation, and Partnerships program (CFDA 47.084) effective June 1, 2026, through May 31, 2027. The project advances high-resolution 3D printing technology for polydimethylsiloxane (PDMS) microfluidic devices—commonly referred to as "labs on a chip"—which are essential tools for disease research, drug testing, and...
- Federal Grant Award Summary Coolaimate, Inc. received a $304,913 Phase I Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084) on October 1, 2025, with completion scheduled for March 31, 2027. The company will develop and validate hybrid silicon photonic tunable lasers—photonic chips that utilize light-based sensing and measurement capabilities with broadly adjustable laser frequencies. The...
- Federal Grant Award Summary Primary Bioscience, Inc. received a $305,000 Small Business Technology Transfer (STTR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084) effective July 15, 2025, with a completion date of June 30, 2026. The company is developing an ultra-sensitive biosensor capable of single-molecule protein analysis and sequencing. The technology integrates a nanopatterned chip with a proprietary amino acid and...
- Federal Project Grant Summary Endura Therapeutics Inc. received a $303,445 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on May 15, 2025, with completion targeted for January 31, 2026. The award funds development of a next-generation sequencing-based platform designed to discover and screen small molecule drugs that target RNA. The primary deliverables include establishing...
- Federal Project Grant Award Summary The National Science Foundation's Directorate for Technology, Innovation, and Partnerships (TIP) awarded $305,000 to a small business under the SBIR Phase I program (CFDA 47.084) to develop a novel gene therapy platform that overcomes the cargo size limitations of adeno-associated virus (AAV) delivery systems. The project, initiated July 1, 2026 with completion targeted for December 31, 2027, focuses on designing and validating a scalable platform to deliver...
- Federal Grant Award Summary Glow Therapeutics Inc. received a $305,000 Small Business Innovation Research (SBIR) Phase I Project Grant from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) to develop a light-activatable nanoplatform for targeted delivery of photodynamic therapy (PDT) and chemotherapy to peritoneal metastasis. The award, issued June 15, 2025, with completion targeted for May 31, 2026, supports translation of a...
- Federal Project Grant Award Summary LR Innovoptics Inc. received a $305,000 Phase I Small Business Innovation Research (SBIR) award from the National Science Foundation's Directorate for Technology, Innovation, and Partnerships (CFDA 47.084) for the period October 1, 2025 through September 30, 2026. The award supports the development of a high-throughput 3D printing platform utilizing two-photon polymerization (TPP) technology to manufacture ultracompact, high-contrast precision glass...